RemChol

Contains CAVADEX

RemChol contains Cavadex, the only cyclodextrin to reduce atherosclerosis and reverses heart disease, with over five years of global sales.

RemChol

With CAVADEX

Restore heart health.

PRECIOUS MOMENTS

MORE TIME WITH THE ONES YOU LOVE

Extend your life with RemChol’s Cavadex to share more cherished moments with those you love

OUR PRODUCTS

RemChol’s Cavadex, reverses arterial plaque to promote lasting heart health

CAVADEX 4X

The Ultimate, Proven Therapy to Reverse Heart Disease and Clear Arterial Plaque

For over six years, our original formulas proved to the world that physically clearing atherosclerosis in humans is possible. Today, CAVADEX 4X™ stands as our final, definitive product. Powered by our newly patented Quad-Dose™ technology, it is the only treatment on earth proven to extract arterial plaque and definitively reverse the progression of cardiovascular disease. It works faster, it extracts more aggressively, and it delivers consistent results that no other therapy or generic cyclodextrin can match.

Real Patients. Undeniable Results.

Read the documented experiences of patients who used our protocol to physically clear atherosclerosis and restore their cardiovascular health.

★★★★★

"I had a calcium test which said I had a 72% artery blockage and now I have 17%. I attribute that to Cavadex. It remarkably opened my arteries. I am not the only one with success from this product."

Joan ✔ Verified Patient

★★★★★

"Five months ago, they wanted to do open heart surgery because I had 3 main arteries blocked. I signed off and came back home to start my Cavadex. I do not feel the pressure pain I used to feel, and I have more strength to walk longer. Cavadex has been a blessing!"

Rosalie ✔ Verified Patient

★★★★★

"I did back-to-back CT angiograms six months apart. I had one artery at over 82% blocked... it is now at 24% blocked. Two other arteries had over 35% reductions. I love the product!"

Larry ✔ Verified Patient

★★★★★

"I had 3 heart attacks and 3 stents. My one artery was 95% blocked. I'm now living a normal life and feeling great. No shortage of breath. I had a stress ECG and an ultrasound 2 months ago and passed with flying colours. Thank you Cavadex."

Brian ✔ Verified Patient

★★★★★

"In November 2024 I had my seventh coronary angiogram. My arteries were totally clear! My cardiosurgeon was amazed. Thank you, as this stuff is literally saving my life."

Brett ✔ Verified Patient

★★★★★

"I had a catheterization about two months ago and my doctor said my arteries looked better than ever. I definitely feel better and my blood pressure has come down quite a bit. In my opinion, it is the only thing that has ever worked for me."

Richard ✔ Verified Patient

★★★★★

"My Dr. has ordered ultrasounds on my neck every year for the last 10 years. I had a plaque buildup in my carotid veins and arteries. They are now clear. It took a while but great success. I also have a clearer mind, less fogginess."

Marilyn ✔ Verified Patient

★★★★★

"My baseline calcium score was 850. Subsequent scans showed regression with new scores dropping to 727 and then the low 600s. I asked my cardiologist if it would be hyperbolic to say Cavadex is the biggest breakthrough ever in cardiology. His response was 'No, that would not be an overstatement.'"

Kenneth ✔ Verified Patient

★★★★★

"My first 90-day supply reduced the blockage in my left carotid artery from 77% to under 50%. This stuff works. I thank you for providing me with an alternative to vascular surgery."

Bob ✔ Verified Patient

★★★★★

"My carotid blockage of 86% that previously 'required surgery' has decreased, and now I only get 'above 70' remarks on my scans. I will continue with Cavadex as it works!"

Sandi ✔ Verified Patient

Latest News

Stay informed with the latest news on why RemChol’s Cavadex works, with doctors praising its unique ability to reverse heart disease by clearing arterial plaque. Dr. James C. Roberts, a renowned cardiologist, highlights Cavadex’s efficacy in enhancing reverse cholesterol transport, noting significant improvements in patients with persistent coronary issues. Experts are increasingly endorsing this pioneering cyclodextrin-based treatment, backed by over five years of global success, as a game-changer in cardiovascular care.